Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798328 · ClinicalTrials.gov registry record
Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
A clinical trial, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- 385
- Enrollment target
NCT02798328: Completed study, sponsored by Haemonetics Corporation.
NCT02798328 is a clinical trial that has completed, run by Haemonetics Corporation. The registered enrollment target is 385 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02798328 has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- 385 participants
- Enrollment target
Study Summary
Observational trial to evaluate the effectiveness of the TEG6s DOAC cartridge to detect and classify the presence of DOAC drugs in a subject.
Interventions
- DEVICE TEG6s DOAC Cartridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-09 |
What the finished NCT02798328 record still lists
NCT02798328 is an observational study that tracks outcomes without assigning an intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which TEG6s DOAC Cartridge is the first listed.
NCT02798328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02798328 about?
NCT02798328 is a clinical study titled "Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System". Observational trial to evaluate the effectiveness of the TEG6s DOAC cartridge to detect and classify the presence of DOAC drugs in a subject.
What is the current status of trial NCT02798328?
This trial is currently completed. The enrollment target is 385 participants. The study started on 2016-08. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02798328?
The interventions under investigation include: TEG6s DOAC Cartridge (DEVICE).
Who is sponsoring clinical trial NCT02798328?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia